SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-032161
Filing Date
2024-02-12
Accepted
2024-02-12 16:34:00
Documents
3
Period of Report
2024-02-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d765670d8k.htm 8-K 29016
2 EX-3.1 d765670dex31.htm EX-3.1 33628
3 EX-3.2 d765670dex32.htm EX-3.2 167391
  Complete submission text file 0001193125-24-032161.txt   231299
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41947 | Film No.: 24620547
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)